Home
The Algo
Contact
News
All articles
IZO
TOC
TOCVAN CEO Interview - Gold Stocks Bull Market 2023? (CSE:TOC)
TOC
April 21, 2023
https://www.blazecapital.com/toc
TOCVAN CEO Interview - GOLD DISCOVERY & SUPERCYCLE (CSE:TOC)
TOC
January 18, 2023
https://www.blazecapital.com/toc
Izotropic CEO & COO Interview - Izoview REVEAL! (CSE:IZO)
IZO
January 11, 2023
https://www.blazecapital.com/izo
Izotropic CEO Interview - Prototype REVEAL SOON! (CSE:IZO)
IZO
November 2, 2022
https://www.blazecapital.com/izo
TOCVAN Ventures - CEO Interview (CSE:TOC)
Justin interviews Tocvan Ventures CEO Brodie Sutherland. Brodie gives insight on his background and expertise, and how he transitioned into the CEO role at Tocvan. Justin and Brodie discuss why Pilar has massive potential for the company.
TOC
August 17, 2022
https://www.blazecapital.com/toc
TOCVAN Ventures - Company Profile (CSE:TOC)
Justin introduces Tocvan Ventures! Tocvan Ventures Corp is a publicly traded, early-stage natural resource company that is engaged in the acquisition, exploration, and, if warranted, development of mineral properties. Gold Mining is more profitable than ever, and with low cost mines with high grades like Pilar located in Mexico, Tocvan Ventures is in an excellent position to benefit from a potential Gold Supercycle!
TOC
August 15, 2022
https://www.blazecapital.com/toc
Izotropic CEO Interview - United States Transition! (CSE:IZO)
Justin welcomes Dr. John McGraw on the show today to discuss why Izotropic is transitioning to the United States and how the transition will help grow the company even faster!
IZO
August 18, 2022
https://www.blazecapital.com/izo
Izotropic CEO Interview - Clinical Trial & CRO Updates! (CSE:IZO)
Izotropic CEO Dr. John McGraw joins Justin today to give updates on how clinical trials are going for the company. Dr. John McGraw explains to the audience what a CRO is, Izotropic chose Icon as the company's CRO after a lengthy interview process. These are some of the steps Izotropic has to take to get the company to commercialization.
IZO
July 27, 2022
https://www.blazecapital.com/izo
Izotropic CEO Interview - Prototype Updates! (CSE:IZO)
Justin welcomes Izotropic CEO Dr. John McGraw, to discuss prototype updates, specifically how the pandemic has impacted the companies timelines. Supply chains and delivery interruptions have impacted many companies during the covid pandemic. Dr. John McGraw states a big goal for Izotropic is to keep the overall timeline on track, in the meantime the company is using this time to optimize the clinical trial path.
IZO
June 30, 2022
https://www.blazecapital.com/izo
Izotropic CEO Interview - Clinical Trials Soon? (CSE:IZO)
Izotropic CEO Dr. John McGraw joins Justin today to give a high level overview of the stages for Clinical Trials with a timeline update for Izotropic Corp. Dr John McGraw goes over what makes the IzoView so unique compared to its competitors!
IZO
April 26, 2022
https://www.blazecapital.com/izo
Izotropic Corp - Company Profile (CSE:IZO)
Justin reviews Izotropic Corporation, a healthcare disruptor stock. In this video Justin breaks down why Izotropic might have the best ROI in the whole stock market! With IzoView, Izotropic is trying to disrupt and tackle many of the challenges currently facing the CT Breast imaging industry.
IZO
April 19, 2022
https://www.blazecapital.com/izo
Izotropic CEO Interview - Prototype, Clinical Trial Updates! (CSE:IZO)
Izotropic CEO Dr. John McGraw sits down with Justin to discuss and give updates on the IzoView Prototype, Clinical Trials, Patent Portfolio, and Strategic Partnerships.
IZO
May 11, 2022
https://www.blazecapital.com/izo